Journal of Jilin University(Medicine Edition) ›› 2022, Vol. 48 ›› Issue (6): 1650-1656.doi: 10.13481/j.1671-587X.20220635
• Review • Previous Articles
Research progress in preoperative evaluation and prognostic related factors of low-risk papillary thyroid microcarcinoma
-
Received:2021-11-18Online:2022-11-28Published:2022-12-07
CLC Number:
- R736.1
Cite this article
share this article
| 1 | LI M M， LDAL MASO， VACCARELLA S. Global trends in thyroid cancer incidence and the impact of overdiagnosis［J］.Lancet Diabetes Endocrinol， 2020， 8（6）： 468-470. |
| 2 | SIEGEL R L， MILLER K D， JEMAL A. Cancer statistics， 2020［J］. CA Cancer J Clin， 2020， 70（1）： 7-30. |
| 3 | KITAHARA C M， SOSA J A. The changing incidence of thyroid cancer［J］. Nat Rev Endocrinol，2016，12（11）： 646-653. |
| 4 | DAVIES L， WELCH H G. Current thyroid cancer trends in the United States［J］. JAMA Otolaryngol Head Neck Surg， 2014， 140（4）： 317-322. |
| 5 | 葛明华， 徐 栋， 杨安奎， 等. 甲状腺良性结节、微小癌及颈部转移性淋巴结热消融治疗专家共识（2018版）［J］. 中国肿瘤， 2018， 27（10）： 768-773. |
| 6 | 田 文， 贺青卿， 朱 见， 等. 机器人手术系统辅助甲状腺和甲状旁腺手术专家共识［J］. 中国实用外科杂志， 2016， 36（11）： 1165-1170. |
| 7 | 赵文君， 于 博， 王慧芳， 等. 低风险甲状腺微小乳头状癌积极监测的研究进展［J］. 中国普外基础与临床杂志， 2021， 28（8）： 1091-1097. |
| 8 | SUGITANI I， ITO Y， TAKEUCHI D， et al. Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma： consensus statements from the Japan association of endocrine surgery task force on management for papillary thyroid microcarcinoma［J］. Thyroid， 2021， 31（2）： 183-192. |
| 9 | ITO Y， MIYAUCHI A， KIHARA M， et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation［J］. Thyroid， 2014， 24（1）： 27-34. |
| 10 | OH H S， PARK S， KIM M， et al. Young age and male sex are predictors of large-volume central neck lymph node metastasis in clinical N0 papillary thyroid microcarcinomas［J］. Thyroid， 2017，27（10）：1285-1290. |
| 11 | 孙 威， 贺 亮， 张 浩. 美国癌症联合委员会甲状腺癌分期系统（第8版）更新解读［J］. 中国实用外科杂志， 2017， 37（3）： 255-258. |
| 12 | LIU C P， CHEN T W， ZENG W， et al. Reevaluating the prognostic significance of male gender for papillary thyroid carcinoma and microcarcinoma： a SEER database analysis［J］. Sci Rep， 2017， 7（1）： 11412. |
| 13 | 《妊娠和产后甲状腺疾病诊治指南（第 2 版）编撰委员会，中华医学会内分泌学会，中华医学会围产医学分会.妊娠和产后甲状腺疾病诊治指南（第2版）［J］. 中华内分泌代谢杂志， 2019， 35（8）： 636-665. |
| 14 | ITO Y， MIYAUCHI A， KUDO T， et al. Effects of pregnancy on papillary microcarcinomas of the thyroid reevaluated in the entire patient series at kuma hospital［J］. Thyroid， 2016， 26（1）： 156-160. |
| 15 | TALLINI G， DE LEO A， REPACI A， et al. Does the site of origin of the microcarcinoma with respect to the thyroid surface matter？ A multicenter pathologic and clinical study for risk stratification［J］. Cancers， 2020， 12（1）： 246. |
| 16 | WANG W H， XU S Y， ZHAN W W. Clinicopathologic factors and thyroid nodule sonographic features for predicting central lymph node metastasis in papillary thyroid microcarcinoma： a retrospective study of 1204 patients［J］. J Ultrasound Med， 2016， 35（11）： 2475-2481. |
| 17 | HUANG K， GAO N N， ZHAI Q X， et al. The anteroposterior diameter of nodules in the risk assessment of papillary thyroid microcarcinoma［J］. Medicine， 2018， 97（10）： e9712. |
| 18 | FENG J W， PAN H， WANG L， et al. Total tumor diameter： the neglected value in papillary thyroid microcarcinoma［J］. J Endocrinol Invest， 2020， 43（5）： 601-613. |
| 19 | ZHOU B， WEI L， QIN J W. Does multifocal papillary thyroid microcarcinoma with a total tumor diameter >1 cm indicate poor biological behavior？ the evidence is insufficient［J］. Endocr Pract， 2021， 27（2）： 131-136. |
| 20 | LUO Y， ZHAO Y， CHEN K， et al. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma［J］. J Endocrinol Invest， 2019， 42（2）： 227-236. |
| 21 | FENG J W， WU W X， HU J， et al. Influence of tumor number on clinicopathologic features and outcomes of patients with papillary thyroid carcinoma［J］. Am J Clin Pathol， 2020， 154（6）： 848-858. |
| 22 | YAN T， QIU W W， SONG J L， et al. Bilateral multifocality， a marker for aggressive disease， is not an independent prognostic factor for papillary thyroid microcarcinoma：a propensity score matching analysis［J］.Clin Endocrinol （Oxf），2021，95（1）：209-216. |
| 23 | BANSAL M， GANDHI M， FERRIS R L， et al. Molecular and histopathologic characteristics of multifocal papillary thyroid carcinoma［J］. Am J Surg Pathol， 2013， 37（10）： 1586-1591. |
| 24 | 李 磊， 杨 洁， 王伟霖， 等. 甲状腺微小癌位置与颈淋巴结转移的关系［J］. 昆明医科大学学报， 2018， 39（6）： 91-95. |
| 25 | 刘晓楠， 张文超. 原发癌灶定位与甲状腺微小癌颈侧区淋巴结转移关系研究［J］.中国实用外科杂志， 2019， 39（7）： 725-728. |
| 26 | LEE Y S， SHIN S C， LIM Y S， et al. Tumor location-dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer［J］. Head Neck， 2014， 36（6）： 887-891. |
| 27 | ITO Y， ODA H， MIYAUCHI A. Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas review［J］. Endocr J， 2016， 63（4）： 323-328. |
| 28 | ITO Y， MIYAUCHI A. Active surveillance as first-line management of papillary microcarcinoma［J］. Annu Rev Med， 2019， 70： 369-379. |
| 29 | 高 明. 甲状腺结节和分化型甲状腺癌诊治指南［J］. 中国肿瘤临床， 2012， 39（17）： 1249-1272. |
| 30 | HUANG C W， CONG S Z， SHANG S Y， et al. Web-based ultrasonic nomogram predicts preoperative central lymph node metastasis of cN0 papillary thyroid microcarcinoma［J］.Front Endocrinol（Lausanne），2021， 12： 734900. |
| 31 | TESSLER F N， MIDDLETON W D， GRANT E G， et al. ACR thyroid imaging， reporting and data system （TI-RADS）： white paper of the ACR TI-RADS committee［J］. J Am Coll Radiol， 2017，14（5）： 587-595. |
| 32 | HAUGEN B R， ALEXANDER E K， BIBLE K C，et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer： the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer［J］. Thyroid， 2016， 26（1）： 1-133. |
| 33 | HUANG X P， YE T T， ZHANG L， et al. Sonographic features of papillary thyroid microcarcinoma predicting high-volume central neck lymph node metastasis［J］. Surg Oncol， 2018， 27（2）： 172-176. |
| 34 | XUE S， HAN Z， LU Q Y， et al. Clinical and ultrasonic risk factors for lateral lymph node metastasis in papillary thyroid microcarcinoma： a systematic review and meta-analysis［J］. Front Oncol， 2020， 10： 436. |
| 35 | TAM A A， OZDEMIR D， AYDIN C，et al. Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer［J］. Endocrine， 2018， 59（3）： 565-572. |
| 36 | SUGITANI I， FUJIMOTO Y， YAMADA K. Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma［J］.World J Surg，2014，38（3）： 673-678. |
| 37 | MAO A H， AN N， WANG J， et al. Association between preoperative serum TSH and tumor status in patients with papillary thyroid microcarcinoma［J］. Endocrine， 2021， 73（3）： 617-624. |
| 38 | KIM H I， JANG H W， AHN H S， et al. High serum TSH level is associated with progression of papillary thyroid microcarcinoma during active surveillance［J］. J Clin Endocrinol Metab， 2018， 103（2）： 446-451. |
| 39 | 田 文， 孙 辉， 贺青卿. 超声引导下甲状腺结节细针穿刺活检专家共识及操作指南（2018版）［J］. 中国实用外科杂志， 2018， 38（3）： 241-244. |
| 40 | 高 明， 葛明华， 嵇庆海， 等. 甲状腺微小乳头状癌诊断与治疗中国专家共识（2016版）［J］. 中国肿瘤临床， 2016， 43（10）： 405-411. |
| 41 | 周 乐， 张 广， 张大奇， 等. 细针穿刺活检及洗脱液检测在甲状腺癌颈淋巴结清扫决策中的应用研究［J］. 中国实用外科杂志， 2017， 37（9）： 1002-1006. |
| 42 | KIM K J， KIM S G， TAN J， et al. BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma［J］. Eur J Cancer， 2020， 124： 161-169. |
| 43 | SALVATORE D， SANTORO M， SCHLUMBERGER M. The importance of the RET gene in thyroid cancer and therapeutic implications［J］. Nat Rev Endocrinol， 2021， 17（5）： 296-306. |
| 44 | 邵 飞， 张晓文， 沈山梅. BRAF、TERTp、RAS、RET/PTC、PAX8/PPAR在甲状腺癌中的研究进展［J］. 医学综述， 2018， 24（7）： 1318-1323. |
| 45 | 罗 晓， 李安华. 甲状腺微小乳头状癌的管理： 现状与争议［J］. 中华医学超声杂志（电子版）， 2019， 16（1）： 6-10. |
| 46 | RAMUNDO V， SPONZIELLO M， FALCONE R，et al. Low-risk papillary thyroid microcarcinoma： optimal management toward a more conservative approach［J］. J Surg Oncol， 2020， 121（6）： 958-963. |
| [1] | Wanyi GU,Cheng ZHI,Chunxia LIU. Intrathyroid thymic carcinoma: A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2022, 48(6): 1580-1585. |
| [2] | Wei JI,Jian DONG,Hong CHANG,Xuemei DU,Hong PENG,Hong XIE,Aimin ZHAO,Wei YAN,Juan BAI,Zhenxing PENG,Jinshu YIN. Influence of chinicopathological characteristics and BRAF V600E gene mutation in cervical lymph node metastasis in patients with papillary thyroid cancer [J]. Journal of Jilin University(Medicine Edition), 2022, 48(4): 995-1002. |
| [3] | Yaoyu FENG, Chenglei ZHANG, Lijuan HOU, Yifu WANG, Xiuling WU, Yunhai MA. Effect of miR-222-3p knockdown targeting PTEN on 131I radiotherapy resistance of thyroid cancer and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 677-686. |
| [4] | . [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 802-810. |
| [5] | Chunying ZHANG,Guangwei YIN,Mingda YOU,Hong CHEN,Yaojie HU,Yanbing LI,Chunyou CHEN. Inhibitory effects of siRNA targeting silencing TAK1 gene on proliferation and migration of thyroid cancer cells and p38 MAPK signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2021, 47(1): 110-117. |
| [6] | Jinghai DU,Xin GUO. Effects of BTg-3 on proliferation, invasion, migration and WNT / β-catenin signaling pathway of thyroid follicular carcinoma cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(6): 1234-1240. |
| [7] | DU Jinghai, CHEN Chunyou, GUO Xin, ZHANG Jing. Effects of silencing Kat5 gene on proliferation and apoptosis of thyroid papillary carcinoma cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(03): 543-550. |
| [8] | ZHANG Lifang, CAI Lin, WANG Yunhua, ZHANG Keshi, WU Rina. Analysis on association between selenoprotein P polymorphism and risk of papillary thyriod carcinoma [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 383-388. |
| [9] | WANG Qi, SA Ri, LIN Qiuyu, ZHAO Hongguang. Protective effect of citric acid on salivary gland function in patients with differentiated thyroid cancer after first 131I treatment [J]. Journal of Jilin University(Medicine Edition), 2019, 45(04): 911-915. |
| [10] | HEI Lijuan, WANG Juanhong, WEI Wei, FANG Hangrong, DUAN Ying, MA Shifen, XU Junrong. Detection of interleukin-6 levels in serum and thyroid tissue of patients with papillary thyroid carcinoma and their significances [J]. Journal of Jilin University(Medicine Edition), 2019, 45(03): 601-605. |
| [11] | . Research progress in radiofrequency ablation in treatment of papillary thyroid carcinoma [J]. Journal of Jilin University(Medicine Edition), 2019, 45(03): 731-735. |
| [12] | . Research progress in thyroid cancer related genes and their applications in clinical diagnosis [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 880-885. |
| [13] | ZHAO Zhiyan, SHENG Jindong, LIU Baoguo. Risk factors of malignant thyroid neoplasms and papillary thyroid cancer level Ⅵ lymph node metastasis [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 334-338. |
| [14] | . Progress research on relationship between Ki-67 and BRAF gene mutation and invasiveness of papillary thyroid carcinoma [J]. Journal of Jilin University Medicine Edition, 2016, 42(06): 1259-1262. |
| [15] | ZHAO Min-xue，LI Bai-wen，ZHU Lin，YE Hong-shan，TIAN Xiao-feng，WEI Liang，CAO Hong. Detection of miR-21 expression levels in carcinoma tissue and serum of patients with papillary thyroid carcinoma and its significance [J]. Journal of Jilin University Medicine Edition, 2014, 40(06): 1237-1240. |
